Alzheimer’s Drug Discovery Foundation’s Diagnostics Accelerator (DxA) Partners with Siemens Healthineers to License DxA’s SpeechDx Dataset, Gold-Standard Dataset for Alzheimer’s Speech Biomarkers

Siemens is the first of many partners to non-exclusively license SpeechDx’s speech and clinical dataset with the goal of developing a speech-based biomarker for Alzheimer’s disease. NEW YORK, May 1, 2025 /PRNewswire/ — The Alzheimer’s Drug Discovery Foundation (ADDF)’s Diagnostics…